- Home
- INGN
INGN
Inogen Inc
as 04-03-2025 3:36pm EST
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | GOLETA |
| Market Cap: | N/A | IPO Year: | 2014 |
| Target Price: | $7.00 | AVG Volume (30 days): | 314.6K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.14 - $13.33 | Next Earning Date: | 05-06-2025 |
| Revenue: | $335,705,000 | Revenue Growth: | 6.35% |
| Revenue Growth (this year): | 7.2% | Revenue Growth (next year): | 1.38% |
Stock Insider Trading Activity of Inogen Inc (INGN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Smith Kevin Raymond Merrill | INGN | CEO and President | Feb 28 '25 | Buy | $8.56 | 11,709 | $100,245.43 | 70,274 | |
| Bourque Michael J. | INGN | EVP, CFO & Treasurer | Feb 28 '25 | Buy | $8.32 | 3,000 | $24,960.00 | 47,646 |
Latest Inogen Inc News
INGN Breaking Stock News: Dive into INGN Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
Inogen (INGN) Down 11.6% Since Last Earnings Report: Can It Rebound?
Simply Wall St.
8 days ago
Favourable Signals For Inogen: Numerous Insiders Acquired Stock
Business Wire
15 days ago
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
Zacks
22 days ago
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
24 days ago
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
Simply Wall St.
a month ago
US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results
Simply Wall St.
a month ago
Inogen Full Year 2024 Earnings: Beats Expectations
Zacks
a month ago
INGN Stock Gains Following Q4 Earnings Beat, Adjusted Gross Margin Up
Compare INGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INGN Inogen Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.